First Time Loading...
O

Oue Lippo Healthcare Ltd
SGX:5WA

Watchlist Manager
Oue Lippo Healthcare Ltd
SGX:5WA
Watchlist
Price: 0.03 SGD 7.14% Market Closed
Updated: May 30, 2024

Net Margin
Oue Lippo Healthcare Ltd

5.1%
Current
25%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.1%
=
Net Income
8m
/
Revenue
159.3m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
SG
Oue Lippo Healthcare Ltd
SGX:5WA
133.3m SGD
5%
US
HCA Healthcare Inc
NYSE:HCA
88.3B USD
8%
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
95.2B SAR
22%
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
15.7B Zac
1%
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
112B CNY
17%
ZA
Netcare Ltd
JSE:NTC
15.4B Zac
5%
US
Tenet Healthcare Corp
NYSE:THC
13B USD
13%
US
Universal Health Services Inc
NYSE:UHS
12.4B USD
6%
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
62.7B BRL
5%
TH
Bangkok Dusit Medical Services PCL
SET:BDMS
433.1B THB
14%
MY
IHH Healthcare Bhd
KLSE:IHH
54.5B MYR
14%
O
Oue Lippo Healthcare Ltd
SGX:5WA
Country SG
Market Cap 133.3m SGD
Net Margin
5%
HCA Healthcare Inc
NYSE:HCA
Country US
Market Cap 88.3B USD
Net Margin
8%
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Country SA
Market Cap 95.2B SAR
Net Margin
22%
L
Life Healthcare Group Holdings Ltd
JSE:LHC
Country ZA
Market Cap 15.7B Zac
Net Margin
1%
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Country CN
Market Cap 112B CNY
Net Margin
17%
N
Netcare Ltd
JSE:NTC
Country ZA
Market Cap 15.4B Zac
Net Margin
5%
Tenet Healthcare Corp
NYSE:THC
Country US
Market Cap 13B USD
Net Margin
13%
Universal Health Services Inc
NYSE:UHS
Country US
Market Cap 12.4B USD
Net Margin
6%
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
Country BR
Market Cap 62.7B BRL
Net Margin
5%
B
Bangkok Dusit Medical Services PCL
SET:BDMS
Country TH
Market Cap 433.1B THB
Net Margin
14%
I
IHH Healthcare Bhd
KLSE:IHH
Country MY
Market Cap 54.5B MYR
Net Margin
14%

Profitability Report

View the profitability report to see the full profitability analysis for Oue Lippo Healthcare Ltd.

Full Profitability Report

See Also

Summary
5WA intrinsic value, competitors valuation, and company profile.
DCF Valuation
5WA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
5WA stock valuation using valuation multiples.
Wall Street Estimates
5WA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
5WA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.1%
=
Net Income
8m
/
Revenue
159.3m
What is the Net Margin of Oue Lippo Healthcare Ltd?

Based on Oue Lippo Healthcare Ltd's most recent financial statements, the company has Net Margin of 5.1%.

ALPHA SPREAD
Join more than 142,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.